Polysialic acid as a drug carrier: evaluation of a new polysialic acid–epirubicin conjugate and its comparison against established drug carriers
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Polysialic acid as a drug carrier: evaluation of a new polysialic acid–epirubicin conjugate and its comparison against established drug carriers
Authors
Keywords
-
Journal
Polymer Chemistry
Volume 4, Issue 5, Pages 1600-1609
Publisher
Royal Society of Chemistry (RSC)
Online
2012-11-30
DOI
10.1039/c2py20876h
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biological Activity of Anti-CD20 Multivalent HPMA Copolymer-Fab’ Conjugates
- (2012) Russell N. Johnson et al. BIOMACROMOLECULES
- Polysialic Acid-Based Micelles for Encapsulation of Hydrophobic Drugs
- (2011) Rebecca A. Bader et al. BIOMACROMOLECULES
- Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances
- (2011) Ehud Segal et al. BIOMATERIALS
- Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel
- (2011) Anat Eldar-Boock et al. BIOMATERIALS
- State of the art in PEGylation: The great versatility achieved after forty years of research
- (2011) Gianfranco Pasut et al. JOURNAL OF CONTROLLED RELEASE
- Synthesis and Biological Evaluation of a Polyglutamic Acid–Dopamine Conjugate: A New Antiangiogenic Agent
- (2011) Cristina Fante et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dendritic Poly(ethylene glycol) Bearing Paclitaxel and Alendronate for Targeting Bone Neoplasms
- (2011) Chiara Clementi et al. MOLECULAR PHARMACEUTICS
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Relevance of folic acid/polymer ratio in targeted PEG–epirubicin conjugates
- (2010) Fabiana Canal et al. JOURNAL OF CONTROLLED RELEASE
- PEG conjugates in clinical development or use as anticancer agents: An overview
- (2009) Gianfranco Pasut et al. ADVANCED DRUG DELIVERY REVIEWS
- Structural and chemical aspects of HPMA copolymers as drug carriers☆
- (2009) Karel Ulbrich et al. ADVANCED DRUG DELIVERY REVIEWS
- Polymer−Drug Conjugates for Combination Anticancer Therapy: Investigating the Mechanism of Action
- (2009) Gianfranco Pasut et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer
- (2009) Corey J. Langer et al. Journal of Thoracic Oncology
- Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer
- (2008) L Paz-Ares et al. BRITISH JOURNAL OF CANCER
- A phase II trial of paclitaxel poliglumex in recurrent or persistent ovarian or primary peritoneal cancer (EOC): A gynecologic oncology group study
- (2008) Paul Sabbatini et al. GYNECOLOGIC ONCOLOGY
- Polymer-drug conjugates: current status and future trends
- (2007) Francesca Greco Frontiers in Bioscience-Landmark
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now